 Researchers are evaluating a new treatment for adult patients with leukemia and lymphoma which involves regular dose chemotherapy and blood stem cell transplantation from an HLA-matched relative, with injections of donor immune cells a type of white blood cells given if you later relapse. In this study, the safety and feasibility of this treatment strategy are being investigated. 